Mydecine Innovations Group Inc. (MYCOF) AI-Powered Stock Analysis
See how Mydecine Innovations Group Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
MYCOF●PNK
HealthcareMedical - Pharmaceuticals
$2.00
$0.24(13.64%)
U.S. Market opens in 46h 28m
Advertisement
Mydecine Innovations Group Inc. (MYCOF)
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerMydecine Innovations Group Inc. (MYCOF) Stock Overall Grade
Mydecine Innovations Group Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Mydecine Innovations Group Inc.'s overall stock rating.
Forecast
C+Score
55/100Financial Growth
AScore
80/100Fundamental Growth
BScore
61/100Key Ratios
BScore
60/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
99/100Analyst Consensus
C+Score
50/100Mydecine Innovations Group Inc. (MYCOF) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 55/100 (C+), reflecting weak confidence in its potential. Financial Growth (80/100, A) and Fundamental Growth (61/100, B) highlight its stability, while Key Ratios (60/100, B) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (99/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Mydecine Innovations Group Inc. stock grade, including financials, comparisons, and forecasts.